1. Cognitive enhancing drugs in aphasia: A vote for hope Marcelo L. Berthier 2. Psycholinguistics of aphasia pharmacotherapy: Asking the right questions Dalia Cahana-Amitay, Martin L. Albert, and Abigail Oveis 3. Dopaminergic therapy in aphasia Sumanjit K. Gill and Alexander P. Leff 4. A clinical study of the combined use of bromocriptine and speech and language therapy in the treatment of a person with aphasia Mandy A. Galling, Neetish Goorah, Marcelo L. Berthier, and Karen Sage 5. Massed sentence repetition training can augment and speed up recovery of speech production deficits in patients with chronic conduction aphasia receiving donepezil treatment Marcelo L. Berthier, Guadalupe Dávila, Cristina Green-Heredia, Ignacio Moreno Torres, Rocío Juárez y Ruiz de Mier, Irene De-Torres, and Rafael Ruiz-Cruces 6. Neuroplasticity, neurotransmitters and new directions for treatment of anomia in Alzheimer disease Adam D. Falchook, Kenneth M. Heilman, Glen R. Finney, Leslie J. Gonzalez-Rothi, and Stephen E. Nadeau 7. Effects of memantine treatment on language abilities and functional communication: A review of data Michael Tocco, Kathryn Bayles, Oscar L. Lopez, Robert K. Hofbauer, Vojislav Pejović, Michael L. Miller, and Judith Saxton
Biography
Marcelo L. Berthier is a member of the Unidad de Neurología Cognitiva y Afasia of the Centro de Investigaciones Médico-Sanitarias at the University of Malaga, Spain, and is interested in using different strategies to treat aphasia. Most of his current work concerns the treatment of post-stroke aphasia combining intensive rehabilitation with drugs.
Guadalupe Dávila is a member of the Unidad de Neurología Cognitiva y Afasia of the Centro de Investigaciones Médico-Sanitarias at the University of Malaga, Spain and is interested in using different strategies to treat aphasia. Most of his current work concerns the treatment of post-stroke aphasia combining intensive rehabilitation with drugs.
